Results 221 to 230 of about 54,991 (287)

Drug-Checking and Monitoring New Psychoactive Substances: Identification of the U-48800 Synthetic Opioid Using Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, and Bioinformatic Tools. [PDF]

Int J Mol Sci
Pereira MB, Família C, Martins D, Cunha M, Dias M, Neng NR, Gaspar H, Quintas A.   +7 more
europepmc   +1 more source

A novel index to measure pre‐planning in the Tower of London task: Test–retest reliability and known‐group validity

British Journal of Psychology, EarlyView.
Abstract The Tower of London (TOL) is a planning task frequently used in clinical settings and research. Planning and execution times are the most common outcome variables despite yielding lower effect sizes in clinical group comparisons and lower test–retest reliability than planning accuracy. Here, it is proposed that planning time be analysed not in
Lena V. Schumacher, Benjamin Rahm, Christoph P. Kaller, Valentin Schyle, Cornelius Weiller, Josef M. Unterrainer   +5 more
wiley   +1 more source

Rapid Determination of Methamphetamine, Methylenedioxymethamphetamine, Methadone, Ketamine, Cocaine, and New Psychoactive Substances in Urine Samples Using Comprehensive Two-Dimensional Gas Chromatography. [PDF]

Metabolites
Chandra Siri DNB, Goh SY, Chong NS, Marriott PJ, Wong YF.   +4 more
europepmc   +1 more source

Attention and vigilance advantages related to formal musical training across childhood, adolescence and young adulthood

British Journal of Psychology, EarlyView.
Abstract Attention and vigilance are fundamental cognitive abilities that develop throughout childhood and adolescence and have been associated with cognitively demanding activities such as formal musical training. This cross‐sectional study examined whether individuals engaged in long‐term musical training show superior attention and vigilance ...
Rafael Román‐Caballero, Laura Trujillo, Paulina del Carmen Martín‐Sánchez, Elisa Martín‐Arévalo, Juan Lupiáñez   +4 more
wiley   +1 more source

Analysis of crude wastewater from two treatment plants in South Wales for 35 new psychoactive substances and cocaine, and cannabis. [PDF]

Sci Rep
Davies B, Paul R, Osselton D, Woolley T.
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

Youth attitudes and behaviours towards new psychoactive substances over the period 2017-2023 – a comparative analysis of trends, determinants and risks

Journal of Health Inequalities
Paulina Wojtyła-Buciora, Wojciech Kapała, Zuzanna Chęcińska-Maciejewska, Katarzyna Sygit, Katarzyna Wojtyła-Blicharska, Franciszek Kaczmarek, Marianna Nowak, Paweł Kalinowski   +7 more
doaj   +1 more source